Halozyme Therapeutics, Inc.Share Price
|
|
Share Price & Volume
| Previous Close | $69.21 | |
| Open | +0.01% | $69.21 |
| Day Low | -1.31% | $68.30 |
| Day High | +0.66% | $69.66 |
| 52-Week Low | -29.72% | $48.64 |
| 52-Week High | +18.81% | $82.22 |
| Day Volume | 60,279 | |
| Average Volume | 2,005,919 | |
| EPS (TTM) | $2.85 | |
| P/E (TTM) | 23.99x | |
| FWD P/E (NTM) | 8.82x | |
| Next Earnings Date | Aug 4, 2026 |
| Market Cap | 8,109,570,810 | |
| Shares Outstanding (Millions) | 118,613,000 | |
| Dividend | - | |
| Beta | 0.88 | |
| ROE | 0.99% | |
| ROA | 0.22% |
Analyst Ratings and Price Targets
Current:
$68.37
Average:
$88.25
(+29.08%)
Low:
$75.00
(+9.70%)
High:
$95.00
(+38.95%)
You need to login to see this data
| Morgan Stanley | Maintains | Overweight | $93.00 | +36.02% | May 11, 2026 |
| HC Wainwright & Co. | Maintains | Buy | $95.00 | +38.95% | Apr 28, 2026 |
| Benchmark | Maintains | Buy | $90.00 | +31.64% | Feb 19, 2026 |
Headquarters
San Diego, CA, USA
Sector
Industry
# of Employees
350